Skip to main content

Covid-19 vaccination in the UK: What does the future hold?

Recently, the UK Government announced that offers of first and second Covid-19 vaccinations will come to an end after 30 June. Ahead of World Immunisation Week, Professor Azeem Majeed from the School of Public Health discusses this major change in national vaccine policy, and why it’s important to stay up to date with Covid-19 booster vaccinations.

The announcement from NHS England that first and second doses of Covid-19 vaccines will no longer be offered to adults after 30 June 2023 signifies a significant change in national vaccine policy. We will all remember the start of the Covid-19 vaccination programme in December 2020, the rapid rollout of vaccines by the NHS, and the enthusiasm for vaccination amongst most sections of the population. Vaccination curbed the impact of Covid-19, leading to large falls in hospital admissions and deaths, and allowing the government to end Covid-19 restrictions.

We are now though entering a new phase in which Covid-19 vaccination will be restricted to older people and those in medical problems that place them at higher risk of adverse outcomes such as hospitalisation and death. The very highest risk groups – such as the immunocompromised and people aged 75 years and over – have been offered booster vaccines every six months for the past two years. Other population groups – such as NHS staff, those aged 50 and over, and people with significant medical problems – have been offered annual booster vaccines.

Improving vaccine uptake

Whether this policy continues in the future will depend on factors such as Covid-19 infection rates and the probability of serious adverse health outcomes from infection in different population groups. But given that Covid-19 infection rates remain relatively high – and are still leading to hospital admissions and deaths in groups such as the elderly – it does look likely that booster vaccines will be a fact of life for many people. Ensuring high risk groups continue to take up the offer of booster vaccines will be a key task for the NHS and public health organisations in England to improve population health outcomes and reduce pressures on the NHS from Covid-19.

This will be challenging to achieve because we have seen a fall-off in the take up of Covid-19 vaccines in the most recent booster campaigns compared to the very high take-up in the first phase of the vaccination programme. We need to continue to emphasise the importance of Covid-19 vaccination and aim to improve vaccine uptake rates – particularly in parts of England that have seen a low take-up of vaccination such as inner city areas of London – and in population groups such as ethnic minorities. As well as positive messages about vaccination, this also requires strong engagement with communities and areas that have had a low uptake of Covid-19 vaccination. Making vaccination easily accessible – for example, by ensuring that vaccination is offered close to where people live and work – is also essential.

One final opportunity

For adults who are currently unvaccinated, there is one final opportunity to take up the offer of Covid-19 vaccination. As a medical doctor and public health specialist, I am strongly encouraging people who have not had their first or second Covid-19 vaccination to come forwards for this before the deadline of 30 June 2023. Vaccination continues to provide good protection against serious illness and death. Even in people who have had a previous Covid-19 infection (which also reduces the risk of serious health outcomes) vaccination still offers additional benefits. People in underserved communities such as the poor and ethnic minorities – and often experiencing the greatest health inequalities – are also the most likely to be under-vaccinated. Vaccination is essential in these groups to reduce health inequalities and improve clinical outcomes.

Although the era of mass population vaccination is ending and we move towards a more targeted vaccine policy in England, the risk of a further wave of serious illness from Covid-19 remains. This could arise either from declining population immunity or from the emergence of a new variant of SARS-CoV-2 (the virus that is the cause of Covid-19) that can bypass pre-existing immunity and cause more serious illness than currently circulating variants. We must therefore remain ready to update our vaccines to deal with new variants of SARS-CoV-2 and once again roll out Covid-19 vaccination in the population should the need for this ever arise in the future.

This article was first published by Imperial College London.

Comments

Post a Comment

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...
Post a Comment
Read more

New NHS community mental health centres in England

The Government has announced it will create over 100 new community mental health centres across England, which will work alongside GPs and other NHS organisations/ The centres will offer offer walk-in support as well as seeing patients referred from elsewhere in the NHS. GPs have long called for faster access to specialist mental health support for patients, so the expansion of community mental health services is a welcome development. If these new centres improve access to multidisciplinary teams, reduce waiting times and provide more integrated care, they can improve patient outcomes while reducing pressure on both general practice and specialist mental health services. Close collaboration between GPs, mental health professionals, social care and the voluntary sector will be essential because many people with mental health problems also have wider social and physical health needs. The success of these centres will depend on how they are implemented. They need to be adequately staffe...
Post a Comment
Read more

Protecting Young People from Meningococcal B Disease: The NHS Targeted Vaccination Programme

Meningococcal group B (MenB) infections are rare but can have devastating consequences. The decision to offer a targeted two-dose vaccination programme to Year 13 students and young people entering university or residential further education reflects concerns about recent outbreaks of meningococcal disease and the higher risk of transmission when large numbers of young adults mix closely for the first time in shared accommodation. The MenB vaccine has a well-established safety record, and evidence from the UK infant immunisation programme has shown substantial reductions in disease among vaccinated children. A targeted programme for those entering higher-risk settings is therefore a reasonable precautionary measure while further evidence is gathered on whether the recent increase in clusters represents a temporary fluctuation in disease patterns or a more sustained change in the epidemiology of MenB infection. The success of the programme will depend on achieving high uptake and ensuri...
Post a Comment
Read more